Cizzle Biotechnology strengthens North American rollout of CIZ1B lung cancer test (LON:CIZ) 2 October 2025
Manx Financial Group New Overdraft Tech Partnership with Fiinu Plc Targets UK Liquidity Crunch (Video)
Roquefort Therapeutics secures exclusivity with Coiled Therapeutics RTO, eyeing AIM relist and NASDAQ (Video)
Finseta Pushes Forward with Strategic Growth Plans Despite Interim Setback – Shore Capital 11 September 2025
Chinese tech stocks gain momentum amid shifting AI landscape | Ruffer Investment Company 21 November 2025
Melrose Industries delivers 14% revenue growth and strong profit momentum in Q4 trading update 14 November 2025
Zigup PLC (ZIG.L) Investor Outlook: Exploring a 38.98% Potential Upside in the Industrials Sector 28 November 2025
XPS Pensions Group PLC (XPS.L): Analysts See 25.72% Upside Potential and Strong Buy Ratings 28 November 2025
Worldwide Healthcare Trust PLC (WWH.L): Investor Outlook on a Healthcare-Focused Asset Manager 28 November 2025
Wizz Air Holdings PLC (WIZZ.L) Stock Analysis: Exploring the 10.3% Potential Upside for Investors 28 November 2025
Cizzle Biotechnology strengthens North American rollout of CIZ1B lung cancer test (LON:CIZ) 2 October 2025
Manx Financial Group New Overdraft Tech Partnership with Fiinu Plc Targets UK Liquidity Crunch (Video)
Roquefort Therapeutics secures exclusivity with Coiled Therapeutics RTO, eyeing AIM relist and NASDAQ (Video)
Finseta Pushes Forward with Strategic Growth Plans Despite Interim Setback – Shore Capital 11 September 2025
Chinese tech stocks gain momentum amid shifting AI landscape | Ruffer Investment Company 21 November 2025
Melrose Industries delivers 14% revenue growth and strong profit momentum in Q4 trading update 14 November 2025
Zigup PLC (ZIG.L) Investor Outlook: Exploring a 38.98% Potential Upside in the Industrials Sector 28 November 2025
XPS Pensions Group PLC (XPS.L): Analysts See 25.72% Upside Potential and Strong Buy Ratings 28 November 2025
Worldwide Healthcare Trust PLC (WWH.L): Investor Outlook on a Healthcare-Focused Asset Manager 28 November 2025
Wizz Air Holdings PLC (WIZZ.L) Stock Analysis: Exploring the 10.3% Potential Upside for Investors 28 November 2025
Centessa Pharmaceuticals (CNTA) Stock Analysis: A Biotech Powerhouse with 42% Upside Potential 21 October 2025
Beam Therapeutics Inc. (BEAM) Stock Analysis: Unpacking a 52% Potential Upside Amid Cutting-Edge Biotech Innovations 21 October 2025
Progyny, Inc. (PGNY) Stock Analysis: Exploring a 43.91% Potential Upside in the Healthcare Sector 21 October 2025
Enovis Corporation (ENOV) Stock Analysis: Exploring a 53% Potential Upside in Healthcare Innovation 21 October 2025
Ultragenyx Pharmaceutical Inc. (RARE): Investor Outlook Reveals 150% Potential Upside Amidst Strong Buy Consensus 21 October 2025
Privia Health Group, Inc. (PRVA) Stock Analysis: 14.90% Potential Upside Beckons Investors 21 October 2025
Edgewise Therapeutics, Inc. (EWTX) Stock Analysis: Exploring a 134.92% Potential Upside in the Biotech Arena 21 October 2025
PTC Therapeutics, Inc. (PTCT) Stock Analysis: Navigating a Niche with Strategic Collaborations and a Robust Pipeline 21 October 2025
Tandem Diabetes Care, Inc. (TNDM) Investor Outlook: Navigating a 33.67% Potential Upside Amidst Industry Challenges 21 October 2025
Immunocore Holdings plc (IMCR) Stock Analysis: Exploring an 83% Potential Upside with Promising Biotech Innovations 21 October 2025
Arcutis Biotherapeutics, Inc. (ARQT) Stock Analysis: A Biotech Play with 11.95% Potential Upside 21 October 2025
LifeStance Health Group, Inc. (LFST) Stock Analysis: Exploring a 61.5% Upside Potential in the Mental Health Sector 21 October 2025
Envista Holdings Corporation (NVST) Stock Analysis: Exploring a 6.34% Potential Upside in the Medical Instruments Sector 21 October 2025
CRISPR Therapeutics AG (CRSP) Investor Outlook: Navigating a 12.15% Potential Upside in Gene Editing Innovations 21 October 2025
CG Oncology, Inc. (CGON) Stock Analysis: A 56% Upside Potential in the Biotech Sector 21 October 2025
Tarsus Pharmaceuticals (TARS) Stock Report: Eye-Catching Growth and Promising Analyst Ratings 21 October 2025
LivaNova PLC (LIVN) Stock Analysis: A 20% Upside Potential in the Medical Devices Sector 21 October 2025
Firering Strategic Minerals Kiln Upgrades, Hydration Circuit and Untapped Margin Potential (Video) 23 September 2025
Acuity RM Group CEO David Rajakovich Unveils AI-Driven Turnaround and New Growth Strategy (Video) 19 September 2025
Manx Financial Group New Overdraft Tech Partnership with Fiinu Plc Targets UK Liquidity Crunch (Video) 18 September 2025
Roquefort Therapeutics secures exclusivity with Coiled Therapeutics RTO, eyeing AIM relist and NASDAQ (Video) 11 September 2025
Ruffer Investment Company reports October gains as equities and UK bonds lift performance 12 November 2025
Cizzle Biotechnology strengthens North American rollout of CIZ1B lung cancer test (LON:CIZ) 2 October 2025
Finseta Pushes Forward with Strategic Growth Plans Despite Interim Setback – Shore Capital 11 September 2025
Chinese tech stocks gain momentum amid shifting AI landscape | Ruffer Investment Company 21 November 2025
Zigup PLC (ZIG.L) Investor Outlook: Exploring a 38.98% Potential Upside in the Industrials Sector 28 November 2025
XPS Pensions Group PLC (XPS.L): Analysts See 25.72% Upside Potential and Strong Buy Ratings 28 November 2025
Worldwide Healthcare Trust PLC (WWH.L): Investor Outlook on a Healthcare-Focused Asset Manager 28 November 2025
Wizz Air Holdings PLC (WIZZ.L) Stock Analysis: Exploring the 10.3% Potential Upside for Investors 28 November 2025
